{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Ffaq-immunotherapy-in-sclc-J_u_KAZm","width":444,"version":"1.0","type":"rich","title":"Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/ec61b327-3a4f-4bed-a4d2-7c7d2df62891/5eb3da0d-eb56-45b1-a579-8ec87061a7cc/onc-2020-asco-lung-sclc-wc-podcasticon-faq-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2460f5f2-7220-415e-aa11-cad2dd007e5b\" height=\"200\" width=\"100%\" title=\"Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast episode, listen to lung cancer experts Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer audience questions from a live CCO Webinar on the topic of immunotherapy in SCLC."}